Hualan Biological Engineering,Inc.’s Net Profit Dropped 10.7% in First Three Quarters of 2022

Hualan Biological Engineering,Inc. (华兰生物工程股份有限公司) (002007.SZ) reported a net profit of 1.1 billion yuan in the first three quarters of 2022, down 10.7% year-on-year.

Meanwhile, the company posted 3.6 billion yuan in revenue, up 7.2% year-on-year.

At the end of the reporting period, it had 14.6 billion yuan in total assets and 2.6 billion yuan in total liabilities, with a liability-to-asset ratio of 17.6%.